Comparative evaluation of hyperthermia heating modalities. I. Numerical analysis of thermal dosimetry bracketing cases.

A method for comparing the relative abilities of different hyperthermia heating modalities to properly heat tumors has been developed using solutions of the bio-heat transfer equation. A single measure, the range of absorbed powers that gives acceptable tissue temperature distributions, is used to characterize the ability of a given heating technique to heat a given tumor. An acceptable tissue temperature distribution is one for which (a) the temperatures in the coolest regions of the tumor are above a minimum therapeutic value, (b) the temperatures in the hottest regions of the tumor do not exceed a maximum clinically acceptable value, and (c) the normal tissue temperatures do not exceed maximum clinically acceptable levels. This measure can be interpreted directly in clinical terms as the range of power settings on the power indicator of a heating device for which acceptable tumor heatings will occur. This paper describes the basis of the method and investigates the role of tumor blood perfusion patterns in determining the size of the acceptable power range. Three tumor perfusion patterns are investigated: uniform tumor perfusion, a concentric annulli perfusion model in which the tumor consists of a necrotic core surrounded by two concentric layers of increased perfusion, and a random perfusion distribution model. The results show that, in general, the uniform and annular perfusion models serve as bracketing case patterns. That is, they give acceptable power range values that are upper and lower limits of the acceptable power ranges obtained for the random perfusion patterns. The method is applied to heating patterns that simulate those obtained from a variety of different available heating techniques, and it is found to be valid for all cases studied. The role of normal tissue limiting conditions is also investigated.

[1]  G M Samaras,et al.  Good thermal dosimetry is essential to good hyperthermia research. , 1978, The British journal of radiology.

[2]  K. Luk,et al.  Clinical experiences with local microwave hyperthermia. , 1981, International journal of radiation oncology, biology, physics.

[3]  A. Smith,et al.  Circulatory and biochemical effects of whole body hyperthermia , 1974, The British journal of surgery.

[4]  Narendra J. Sheth,et al.  Statistical Design and Analysis of Engineering Experiments , 1973 .

[5]  R. Dedrick,et al.  Distribution of anticancer agents in spontaneous animal tumors. I. Regional blood flow and methotrexate distribution in canine lymphosarcoma. , 1974, Journal of the National Cancer Institute.

[6]  A. Roberts,et al.  Effect of marked hyperthermia upon the canine bladder. , 1972, The Journal of urology.

[7]  R. Roemer,et al.  Magnetic induction heating of tissue: numerical evaluation of tumor temperature distributions. , 1983, International journal of radiation oncology, biology, physics.

[8]  Arthur W. Guy,et al.  Evaluation of a Therapeutic Direct-Contact 915-MHz Microwave Applicator for Effective Deep-Tissue Heating in Humans , 1978 .

[9]  J. Larkin,et al.  Systemic thermotherapy: Description of a method and physiologic tolerance in clinical subjects , 1977, Cancer.

[10]  T. Shawker,et al.  Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. , 1979, Annals of internal medicine.

[11]  A. Smith,et al.  Clinical Effects of Whole-body Hyperthermia in Advanced Malignancy , 1974, British medical journal.